Literature DB >> 1597475

A novel mechanism for achieving transgene persistence in vivo after somatic gene transfer into hepatocytes.

J M Wilson1, M Grossman, J A Cabrera, C H Wu, G Y Wu.   

Abstract

Infusion of hepatocyte-specific DNA-protein complexes into rats leads to transient recombinant gene expression in liver. The eventual deterioration of gene expression is due in part to instability of the targeted DNA. In a previous report, we noted retention of transgene sequences in liver and persistent recombinant gene expression when the animals were subjected to partial hepatectomy following in vivo gene transfer. In an attempt to define the mechanism(s) responsible for persistent gene expression following partial hepatectomy, we characterized the molecular state of the retained, liver-associated transgenes. Southern blot analysis of DNA from liver tissues harvested various times after in vivo gene transfer and partial hepatectomy (10 min to 11 weeks) demonstrated high levels of transgene DNA (100-10,000 copies/cell). The predominant form of this DNA appeared to be episomal based on analyses of uncut DNA or DNA restricted by an endonuclease with one site in the plasmid. Livers from several animals contained a small proportion of transgene sequences of unknown structure. The existence of episomal DNA in liver was confirmed in experiments in which intact plasmid was rescued from total hepatocyte DNA by transformation of bacteria. Both strands of DNA in the liver-associated plasmid retained a bacterial pattern of methylation suggesting that the plasmid had not replicated in the eukaryotic cell. These results are consistent with the hypothesis that the majority of transgene sequences are retained as stabilized plasmids. The specific form of DNA which is transcriptionally active was not identified in these studies. This represents a new mechanism for retaining foreign DNA in eukaryotic cells in vivo and has implications both for the development of somatic gene therapies and the pathogenesis of viral diseases.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1597475

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Liver-directed gene transfer and application to therapy.

Authors:  V Sandig; M Strauss
Journal:  J Mol Med (Berl)       Date:  1996-04       Impact factor: 4.599

Review 2.  Pharmaceutical approach to somatic gene therapy.

Authors:  F D Ledley
Journal:  Pharm Res       Date:  1996-11       Impact factor: 4.200

3.  Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells.

Authors:  T Bettinger; R C Carlisle; M L Read; M Ogris; L W Seymour
Journal:  Nucleic Acids Res       Date:  2001-09-15       Impact factor: 16.971

4.  Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake.

Authors:  J C Perales; T Ferkol; H Beegen; O D Ratnoff; R W Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  Increased gene expression after liposome-mediated arterial gene transfer associated with intimal smooth muscle cell proliferation. In vitro and in vivo findings in a rabbit model of vascular injury.

Authors:  S Takeshita; D Gal; G Leclerc; J G Pickering; R Riessen; L Weir; J M Isner
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

6.  A bovine papillomavirus-1 based vector restores the function of the low-density lipoprotein receptor in the receptor-deficient CHO-ldlA7 cell line.

Authors:  Jaana Tammur; Hiljar Sibul; Ene Ustav; Mart Ustav; Andres Metspalu
Journal:  BMC Mol Biol       Date:  2002-04-19       Impact factor: 2.946

7.  Targeted cationic poly(D,L-lactic-co-glycolic acid) nanoparticles for gene delivery to cultured cells.

Authors:  Sonsoles Díez; Itziar Miguéliz; Conchita Tros de Ilarduya
Journal:  Cell Mol Biol Lett       Date:  2009-02-04       Impact factor: 5.787

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.